Cyclomics is a Dutch startup, founded by scientists, with the ambition to revolutionize cancer diagnostics and treatment monitoring. Specializing in the Health Care industry, the company was established in 2018 and is headquartered in The Netherlands. The most recent investment of €71.43K came in the form of a grant investment on 01 January 2019 and was provided by EASME - EU Executive Agency for SMEs.
Cyclomics
A Dutch startup, founded by scientists, with the ambition to revolutionize cancer diagnostics and treatment monitoring.
Founded 2018
The Netherlands
14 employees
Grant
Total: $71.43K
Health Care
The Netherlands
14 employees
Grant
Total: $71.43K
Health Care
General Information
Company Name
Cyclomics
Founded Year
2018
Location
The Netherlands
The Netherlands
Employees
14
Industries
Health Care
Funding Stage
Grant
Offices
as of Sep 2026
Amsterdam, The Netherlands
Utrecht, The Netherlands
BounceWatch is an independent company data service, not affiliated with Cyclomics. To contact Cyclomics, visit cyclomics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
The Netherlands Market
Health Care
Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.
Event Participation
Sep 24, 2026
Cyclomics participated as an exhibitor at the European Association for Cancer Research (EACR) Liquid Biopsies conference in Lyon.
New Partnership
Sep 14, 2026
Cyclomics announced a co-sponsorship partnership with Roche Diagnostics Nederland for an upcoming event.
Major Customer Win
Sep 01, 2026
Princess Máxima Center for Pediatric Oncology now uses Cyclomics' Epinn® technology for neurosurgical decisions, achieving 98.8% correct diagnosis.
About Cyclomics
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | €71.43K | 1 |
EASME - EU Executive Agency for SMEs
|
01 Jan 2019 |
Cyclomics Alternatives & Competitors
Cyclomics vs
Stratipath
Sweden
The right treatment for every patient. AI-based precision diagnostics to improve cancer treatment de...
Seed
17 employees
Health Care
Cyclomics vs
Cyclomics vs
Epic Sciences
United States
Epic Sciences, Inc. is developing novel diagnostics to personalize and advance the treatment and man...
Series G
89 employees
Biotechnology, Health Care
FAQ About Cyclomics
A Dutch startup, founded by scientists, with the ambition to revolutionize cancer diagnostics and treatment monitoring.
Cyclomics was founded in 2018.
Cyclomics is headquartered in The Netherlands. As of Sep 2026, it also has offices in Amsterdam, The Netherlands and Utrecht, The Netherlands.
Cyclomics operates in Health Care.
Cyclomics has approximately 14 employees.
Cyclomics has completed 1 funding round, raising a total of $71.43K. The latest funding stage is Grant.
Top alternatives and competitors to Cyclomics include Stratipath, Dxcover, Epic Sciences, Mindpeak, OraLiva, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cyclomics and Stratipath are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Cyclomics, https://bouncewatch.com/company/cyclomics, updated 25 September 2026. When citing, please name BounceWatch and link this page.
